Status: current, Primitive. Date: 30-Apr 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1884631000168116 | glycomacropeptide formula with docosahexaenoic acid and low phenylalanine powder for oral liquid, 27 g sachet (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1884641000168113 | glycomacropeptide formula with docosahexaenoic acid and low phenylalanine powder for oral liquid, 27 g sachet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| glycomacropeptide formula with docosahexaenoic acid and low phenylalanine powder for oral liquid, 27 g sachet | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| glycomacropeptide formula with docosahexaenoic acid and low phenylalanine powder for oral liquid, 27 g sachet | Is a | glycomacropeptide formula with docosahexaenoic acid and low phenylalanine | true | Inferred relationship | Some | ||
| glycomacropeptide formula with docosahexaenoic acid and low phenylalanine powder for oral liquid, 27 g sachet | has manufactured dose form | powder for oral liquid | true | Inferred relationship | Some | ||
| glycomacropeptide formula with docosahexaenoic acid and low phenylalanine powder for oral liquid, 27 g sachet | has unit of use | sachet | true | Inferred relationship | Some | 1 | |
| glycomacropeptide formula with docosahexaenoic acid and low phenylalanine powder for oral liquid, 27 g sachet | has intended active ingredient | glycomacropeptide formula with docosahexaenoic acid and low phenylalanine | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| PKU Sphere15 Chocolate powder for oral liquid, 27 g sachet | Is a | True | glycomacropeptide formula with docosahexaenoic acid and low phenylalanine powder for oral liquid, 27 g sachet | Inferred relationship | Some | |
| PKU Sphere15 Red Berry powder for oral liquid, 27 g sachet | Is a | True | glycomacropeptide formula with docosahexaenoic acid and low phenylalanine powder for oral liquid, 27 g sachet | Inferred relationship | Some | |
| PKU Sphere15 Vanilla powder for oral liquid, 27 g sachet | Is a | True | glycomacropeptide formula with docosahexaenoic acid and low phenylalanine powder for oral liquid, 27 g sachet | Inferred relationship | Some | |
| glycomacropeptide formula with docosahexaenoic acid and low phenylalanine powder for oral liquid, 30 x 27 g sachets | has MPUU | True | glycomacropeptide formula with docosahexaenoic acid and low phenylalanine powder for oral liquid, 27 g sachet | Inferred relationship | Some | 1 |
Reference Sets
List of Excluded Medicinal Items reference set
Medicinal product unit of use reference set
FHIR